Mengchao Wei

426 total citations
21 papers, 315 citations indexed

About

Mengchao Wei is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengchao Wei has authored 21 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 9 papers in Hepatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengchao Wei's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Renal cell carcinoma treatment (3 papers). Mengchao Wei is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Renal cell carcinoma treatment (3 papers). Mengchao Wei collaborates with scholars based in China and Hong Kong. Mengchao Wei's co-authors include Zhenwei Peng, Shuling Chen, Jie Mei, Jing‐Wei Gao, Hui Huang, Manxia Lin, Adham Sameer A. Bardeesi, Jiaping Li, Pin‐Ming Liu and Kun Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Radiology.

In The Last Decade

Mengchao Wei

20 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengchao Wei China 9 135 81 63 59 47 21 315
Yaowei Bai China 10 154 1.1× 105 1.3× 52 0.8× 40 0.7× 33 0.7× 44 296
Jingyao Huang China 11 129 1.0× 48 0.6× 58 0.9× 79 1.3× 32 0.7× 33 319
Feng Shen China 13 114 0.8× 193 2.4× 69 1.1× 88 1.5× 37 0.8× 27 391
Zhi‐Cheng Jin China 11 146 1.1× 59 0.7× 48 0.8× 45 0.8× 50 1.1× 19 298
Xiaofeng He China 11 102 0.8× 43 0.5× 111 1.8× 25 0.4× 22 0.5× 48 348
Xiaopeng Guo China 11 77 0.6× 23 0.3× 56 0.9× 82 1.4× 24 0.5× 31 337
Qungang Shan China 13 153 1.1× 106 1.3× 70 1.1× 83 1.4× 20 0.4× 24 432
Fumio Kotake Japan 8 119 0.9× 103 1.3× 97 1.5× 72 1.2× 12 0.3× 19 378
Jung Hee Kwon South Korea 8 144 1.1× 186 2.3× 100 1.6× 96 1.6× 15 0.3× 12 421

Countries citing papers authored by Mengchao Wei

Since Specialization
Citations

This map shows the geographic impact of Mengchao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengchao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengchao Wei more than expected).

Fields of papers citing papers by Mengchao Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengchao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengchao Wei. The network helps show where Mengchao Wei may publish in the future.

Co-authorship network of co-authors of Mengchao Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Mengchao Wei. A scholar is included among the top collaborators of Mengchao Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengchao Wei. Mengchao Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Mengchao, et al.. (2025). A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries. Scientific Reports. 15(1). 238–238.
2.
3.
4.
Yang, Wenjie, Hualin Chen, Jie Dong, et al.. (2023). SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway. iScience. 26(9). 107617–107617. 8 indexed citations
5.
Wei, Mengchao, et al.. (2023). Surgery or external beam radiation for solitary small hepatocellular carcinoma. Journal of Cancer Research and Therapeutics. 19(Suppl 1). S166–S171. 1 indexed citations
6.
7.
Wei, Mengchao, Manxia Lin, Xian Zhong, et al.. (2022). Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma. Annals of Surgical Oncology. 29(8). 5144–5153. 2 indexed citations
8.
Yang, Wenjie, et al.. (2022). Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy. SHILAP Revista de lepidopterología. 23(3). 471–482. 6 indexed citations
9.
Wei, Mengchao, Yaojun Zhang, Minshan Chen, et al.. (2022). Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy. Frontiers in Oncology. 12. 868429–868429. 6 indexed citations
10.
Chen, Yong, Mengchao Wei, Shunli Shen, et al.. (2022). The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer. International Journal of Radiation Oncology*Biology*Physics. 113(4). 816–824. 4 indexed citations
11.
12.
Wei, Mengchao, Shuling Chen, Jiali Li, et al.. (2020). Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A. Annals of Surgical Oncology. 27(10). 3740–3753. 5 indexed citations
13.
Chen, Shuling, Huilin Jin, Zihao Dai, et al.. (2019). Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma. Cancer Medicine. 8(4). 1530–1539. 13 indexed citations
14.
Peng, Zhenwei, Shuling Chen, Mengchao Wei, et al.. (2018). Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation. Radiology. 287(2). 705–714. 61 indexed citations
15.
Wang, Zongren, Han Xiao, Guangyan Wei, et al.. (2018). Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model. BMC Cancer. 18(1). 1108–1108. 5 indexed citations
16.
Chen, Shuling, Zhenwei Peng, Mengchao Wei, et al.. (2018). Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis. BMC Cancer. 18(1). 392–392. 17 indexed citations
17.
18.
Liu, Baoxian, Mengchao Wei, Furong Liu, et al.. (2018). Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis.. PubMed. 10(8). 2685–2695. 5 indexed citations
19.
Bardeesi, Adham Sameer A., Jing‐Wei Gao, Kun Zhang, et al.. (2017). A novel role of cellular interactions in vascular calcification. Journal of Translational Medicine. 15(1). 95–95. 62 indexed citations
20.
Peng, Jianmin, Jiacheng Lin, Mengchao Wei, et al.. (2016). Enhanced antimicrobial activities of silver-nanoparticle-decorated reduced graphene nanocomposites against oral pathogens. Materials Science and Engineering C. 71. 10–16. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaowei Bai Breakdown of academic impact, for papers by Jingyao Huang Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Zhi‐Cheng Jin Breakdown of academic impact, for papers by Xiaofeng He Breakdown of academic impact, for papers by Xiaopeng Guo Breakdown of academic impact, for papers by Qungang Shan Breakdown of academic impact, for papers by Fumio Kotake Breakdown of academic impact, for papers by Jung Hee Kwon
Rankless by CCL
2026